Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

MSL Talk

Social Media Listening Evolved

Aug 5, 202531 minVideo
ShareXLinkedInFacebookWhatsAppEmail

In this episode, Tom Caravela, Conor McGladrigan, and Kevin Peterson discuss the evolving role of social media listening in Medical Affairs. They discuss the significance of social media listening for Medical Science Liaisons (MSLs) and how insights can be leveraged to enhance medical strategies. The conversation covers engagement with Digital Opinion Leaders (DOLs) and the legal considerations for social media interactions. They highlight best practices for MSLs in the digital realm and the importance of collaboration between commercial and medical teams. The episode also explores the rise of tech-savvy MDs, the integration of AI, and the necessity for MSLs to embrace new technologies.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show.

0:01Hey, guys. Welcome to the podcast. Excited very excited for this topic. Not one that I haven't covered before, but a very popular topic. We're gonna talk about social media listening evolved. So, guys, I feel like every time we talk about this, there's a more and more interest, more and more questions, which is why I wanted to bring these two special guests along here so that we can talk about it. So before we, you know, go too far ahead, why don't you guys introduce yourselves?

0:36So we have Connor and Kevin. Connor, let's start with you. Quick intro. Sure. Hi, everyone. I'm Connor McLavrigan, and currently a senior medical science liaison at Takeda Oncology and pharmacist by training. Quick disclaimer. Views and opinions today are my own and not reflective of my employer. Thank you so much, Tom, for having us. Yeah, man. I'm excited. And Kevin? Yeah. Kevin Peterson. I'm a senior MSL at Gilead, also a pharmacist. So we're gonna get the pharmacist opinion today.

1:06Yep. And, again, you know, I just wanna emphasize these are my opinions, so, no no other bias in here but my own. Awesome. Awesome. Well and you guys you guys were were actually two people that came to me through our my dear friends and our sponsor for today's episodes, which is Medical Watch. So guys, you have heard me talk about Medical Watch before on this show. If you have not signed up and tried it, like, what are you waiting for?

1:39It's time. Sign up is free. You go to medical.watch, and you can sign up for free. And, basically, Medical Watch helps you understand what HCPs are saying about your products and the disease states that you specialize in on social media. So why wouldn't you do it? So you guys do that. We're gonna talk about that stuff right now because this is going to be almost like a continuation from some of the other discussions that we've had on social media listening.

2:09But let's start with what I'd like to do is start with Connor and go kind of basic and just talk about, you know, what what is social media listening? Why is it relevant to medical affairs? And how do you do it? Yeah. Thank you again, Tom, for having us. It's a privilege to be on that podcast and, the opportunity to kind of set up the background for this. So, I mean, let's face it, right? Online conversations about science, data, therapeutics, disease landscape, everything.

2:40It's happening all the time, whether we're paying attention to it or not. We see a peak, at least I work in the oncology space. So we see a peak around conferences, key data releases, major publications, and there's a lot of information to be gleaned there, which is what makes it important for medical affairs. Right? Like, we're paying attention to podium presentations. We're paying attention to what's happening in scientific exchange because we're getting insights and other valuable information from it. And this online exchange, this online discourse that's happening is another source for us to

3:11gather this information and kinda contextualize it against those other sources, because there's a lot of information that we can get from kind of a online public square in a sorts or in a sense. The beauty of it being public, you would ask, you know, how do you do it? I mean, I can pull up my phone right now and pull up X, LinkedIn, or any number of other social media platforms and kinda get information on some of the therapeutics. You do have to keep in mind if you're you're working for an organization or an institution that has limitations on these, it's probably gonna be with engagement or even what you can

3:41do. But so you wanna be careful with that. But as you mentioned, our sponsor or the sponsor for the show, Medical Watch, is is one of these tools that you can use. It's it's one I personally like to use because it it's I found it to be easiest. So there's a lot of these platforms that you can use that either pull from Twitter or, like, every Internet source available, even potentially Reddit threads. Some you can search by keywords and some are h HCP specific. So, I mean, you have the Internet. You could do the digging yourself, or you could use one of these tools that kinda aggregates things for you depending on what's gonna be most valuable, for you and your role.

4:16Awesome. Yeah. You know, just just to kinda add to that, I think that, you know, there everybody's got a platform out there that that works. I think it's you know, using multiple platforms is really valuable for for an MSL because there's just so much out there. But, you know, really trying I think we're gonna try to talk a little bit more about how in the field we kinda use this. And I think when you're listening to these things, you know, find your find your KOLs that are active and and what platform they use. And I think that that also helps you.

4:47Yeah. I think some of the most successful MSLs out there that I'm following, that I know, that I'm having conversations with are digital first. They're definitely taking that, the the digital part of their role very seriously and utilizing the digital tools and artificial intelligence tools that are available to them so that it can make them more efficient and better prepared with their KOLs and and for their meetings. So, this is awesome. So now you get the information, and then what do you do with it?

5:22Well, I tell you what, Tom. That's a great question. And I think, you know, you you can really become bogged down by the the sheer volume of information that's out there. Mhmm. And I think that's where, you know, you really have to to be careful with what you're listening to and make sure that you categorize some of these insights that are happening. Because every influencer, every digital person that's out there, you know, there's different degrees of of education that they have and maybe what they're how they analyze things.

5:52But as a field MSL, I think it's really important to see what your, you know, in the people that in your territory are actually commenting about. And it's also important to see if people in your territory are are even liking or retweeting some of the stuff from maybe some, global MS or global KOLs. And really keep track of that because I think that's where, you know, there could be talking points that are in there that once you've you've seen that maybe somebody has has liked

6:22or retweeted something that was, you know, maybe a congress presentation or maybe even something of of a comment on a guideline, it's real important to make sure that that you've got that kind of in your back pocket because it is an opportunity for you to be able to discuss that with your KOL. Even if they're not a digital KOL, it's it's really how they're interacting with some of some of the larger, influencers that are out there. Mhmm. Right. I I couldn't agree more, Kevin.

6:53Even thinking about, like so there's obviously, we're talking about probably some of the most prolific people online, but, a lot the vast majority, myself included, are mostly consumers. Right? Like, I'm not creating a lot of content, but I'm consuming a lot content. And you're right. Social media gives you a very unique opportunity to see what's being consumed because it's a it's a way to say, like, hey. I share that thought or sentiment or other thing, and to take that into a meeting makes that meeting that much more effective. Rather than going in blind, you can say, hey. You know, I saw you commented on this guideline or you shared this data.

7:26What what made you do that? What made it impactful? And you can have so much better discussions in the field by having that level of preparedness and that level of awareness. And it and it's key, I think, for you to know who your who your customers are following. Mhmm. Because you can go in and look and see who who somebody is following. And I think that that also gives you a talking point. You know, they may agree or even disagree with their opinion. And I think that's an important part to to really dive down and maybe get an insight that

7:58that you can take back to your, to your company and and have maybe even a deeper discussion point internally on something like that. Yep. So let's talk about you mentioned DOLs, digital opinion leaders. Let's talk about these guys and gals. Sure. How do they fit into this? Yeah. So it's interesting, Tom, because you've had a few guests come on, and I've heard varying definitions of what this looks like. And my theory for that is it's probably because, you know, many of us are working in

8:29different therapeutic areas. Mhmm. Someone who's a a digital opinion leader or DOL for me in oncology, it it may look very different for someone in, say, the cardiovascular or obesity space or or some other area. So what I've found, particularly in oncology, you really kind of have, like, three elements that come together. One, you have someone who's an expert in the field in some way. Right? Because they have to have some level of credibility, some reason for people to be listening to them for the information that they're providing. And two, the you want the audience to primarily be HCPs.

9:02Those are the ones that we're trying to work with in terms of research and education and providing fair and balanced information to make sure that, you know, they have everything they need when they're seeing patients. Right? So you want you would expect someone to be credible to be the one who's putting out the information. You would expect the HCP audience to be there. And then, of course, you know, digital, they have to have an online presence in some way, or not I shouldn't say some way, in a in a very significant way. Right? And the way I kinda think of this, it makes it really easy, is I think of it like a digital

9:34podium. Like, we're paying attention to podium presenters and speakers because we know how important it is in in the way that they deliver their message and that they're informed too on the data so that they're delivering it appropriately. And this is another podium in a sense. So it's important that they're well informed about the different therapeutic options that are available in a in a particular space and the landscape and everything and that the data is is really clear in a fair and balanced way. Yeah. I think that opportunity for us to really make sure that the people that you're listening to

10:06are the ones that do have following. You know, I think that's you know, I use the term influencer here a few different times, and I think that that is, what it really comes down to is, but at the same time, the credibility and how they've what have they done in the past to deserve to be an influencer, I think is a key thing that has to be discerned you know, before you really start to to grab a hold of what maybe someone is saying. So be be careful is probably the first thing I could say here is don't don't take everything

10:39that you that you hear from someone who's got the most likes is necessarily what what is practice changing. Well, I I love that you brought up the term influencer too because I I feel like a DOL is different. Yes. They're influential in what they're doing, but I feel like influencers are I I don't wanna say targeted to a more general audience, but they're appealing to a more general audience. Right? And so that may be relevant for, like, our patient advocacy colleagues because the audience is probably gonna be mostly patients or or something like that. Right? But influencers, at least, maybe I'm biased in the oncology space, but I would be kinda

11:12nervous if my oncologist was taking advice from an influencer, say, like, for an oncologist DOL. So that's that's kind of how I think about it, and that may change as you go through the spectrum of some of the different disease states. But, one of the things that I think about in terms of categorizing who is a DOL and then prioritizing them for engagements and other things. So like you said, you gotta make sure you have the right folks and then finding opportunities to to work with and engage with them. Yeah. It's such a good point because, you know, there's the these quote unquote influencers

11:42that are out there, you really have to vet these folks out and see who's legit and who is who's someone that you wanna align with and who's someone you don't for whatever reason. Mhmm. So as we're talking about DOLs, so once you identify them or or it becomes apparent who the key ones are, how do you work together with them? That's a great question. I think it's it's unanswered, honestly, at this point.

12:14I I think we we're still kinda learning how to how to work with people. And I think as an MS as a field MSL, it's different than what you have for someone who's in your marketing department or someone who's in your patient advocacy department. I think you really need to, first of all, first off is the vetting process has to be very important. And I think it is somebody from a if you're at a local level, you're out in the field, you know, I think engaging with them and seeing, you know, what is it that that how our company can can interact with them. Now, you know, you this may be above the field MSL role, but sometimes, you know, maybe is

12:49there educational opportunities for them? Is there some sort of a a sponsorship? You know, that's starting to get into that influencer world there where, you know, there you you don't wanna necessarily just go for clicks. But I think one of the things that, you know, you you need to make sure that you you understand what what their purpose is. You know? And I think that's how you start to work with them and bring to them information that that really is relevant to, you know, what what they're thinking.

13:20And, really, honestly, if they're somebody who has a tremendous amount of followers, you wanna make sure that the information that they're putting out is correct. Mhmm. And and it is something that that is, you know, in in line with maybe what you're trying to bring out also. So I think it it again, we could probably go on an entire show here talking about this and and make it very, very detailed. But I think from the surface, it you you do need to make sure that you, understand what their purpose is, and that and that's asking questions.

13:53Yeah. I couldn't agree more. Listening, figuring out what's gonna add value for them, and sometimes it is making those connections to other parts of the company. Right? Like, that that is adding value in itself is well, maybe they should speak with the patient advocacy group because they're they're active online, it's primarily towards the patient community or patient advocacy community. So making sure that you're ready to and just as Kevin said, listen, understand what what's going to meet their needs, and then making sure that you do that, to the best that you can. Yeah. And, Kevin, you reminded me.

14:24You said, you know, we could do a whole episode just on DOLs. Like, shameless plug, there are episodes on the MSL talk podcast that we talk about DOLs. As matter of fact, I just did one recently with Paul Ward. Big shout out to Paul. Awesome awesome dude. So check that episode out if you're interested, if you haven't heard it yet. It it definitely ties in with all this. And and if you've listened to this next question, like, if you've listened to other episodes that I've done with on social listening, this next question is a big one.

15:00Because what I want to know from you guys is how then, knowing what we know and what you guys have have already discussed, how then has social media listening evolved? Yeah. I I mean, that's the the big question. Right? And and not to those other episodes are fantastic. Highly recommend listening to them. Not to this I'm gonna over distill them in a sense. But it seems like the standard right now and, Kevin, Tom, correct me if I'm wrong. But it's it's that we're listening to what's going on.

15:30We're bringing back the insights. We're maybe using it for pre call planning. And that's the extent of where we are probably as a whole across medical affairs, at least as far as what I could tell from listening to those others, those other guests and and talking to colleagues and other things. And and I think there are opportunities here to go beyond that. So one, in terms of taking in, you know, what can we learn from DOLs? And one of the things that I think DOLs do very, very effectively is they take very

16:00complex information, distill it into something that's very easily communicated, and disseminate it in bite sized information. And and they do that through a digital platform. Sounds probably very familiar to, you know, a key skill of MSLs. Right? It's taking that complex information, distilling it down, and communicating it effectively. And I think sometimes when I'm going into an engagement with you know, sometimes I've got a thirty, forty, 50 slide slide deck. And I'm like, maybe we could learn a thing or two in terms of our our medical material

16:30preparation. Right? Maybe we could use some of their their teachings in terms of if they're using an infographic to teach a topic, maybe we can use something like that. Right? So it maybe it's partnering with them to figure out, hey. What's gonna communicate our data most effectively? I mean, right now, we're using slides. Is there a better way that we can do it? Another thing that I think about too is what can we do with this information? We were it's all in the public form. We can collect it either manually or or through some kind of platform. And Kevin kinda brought this up earlier where he was talking about the frequency of things.

17:04I think the frequency of when you're hearing things can tell you quite a bit, whether it especially for new data. Right? So you think about a conference like ASCO. If you can track, you know, what's happening with different therapeutics, what's happening with different studies, And you look at it and you see a big spike over a six month period like, hey. Wow. Something you know, data was released and now people are talking about it. That probably tells you that that data is impactful. Conversely, you know, you have a big data release and you're not hearing any chatter. What does that say about your data too?

17:35And then beyond that, you can run sentiment analysis. Tom, you mentioned AI earlier. Right? Like, we have these large language models. Is it perfect? Absolutely not. Is it okay? Yeah. I mean, at least right now, and it's only gonna get better. So you could also do like, look at okay. There were a lot of posts. Let's analyze the sentiment on them. Let's see kind of what's the what's happening here in the background. And and these are just a few ways that you can start taking, you know, baseline level of, okay. You've gone through the process of listening. You're gathering these insights.

18:06You're using it for pre call planning. Here are some of the things that you can start to layer on because you're already doing the work, and now this is just a little bit more that you can get even more out of. You know, and and to add to that shameless plug for MedWatch here, but I think, you know, you do there is a lot of information that comes out at a at a conference. And I think really taking that information and using a company or using a platform that is takes a little bit of the workout for the MSL. Because when you're at a conference, you're busy.

18:37And, you know, spending time online is is very difficult. And I think being able to have something, a platform that is able to condense some of this down and bring that sentiment you know, I I I echo what Conor said here. You know, there's there's two sides of this coin. It's great to have a lot of chatter, but what is the sentiment behind that chatter? And if there's no chatter, why is there none? And I think those are where some of these tools that that are out there that are available can be very valuable because they can analyze that very quickly.

19:10And and, you know, the digital world moves extraordinarily fast. This this isn't, you know, this this isn't your grandfather's MSL team. Right? I mean, you you need to be able to move quickly. And sometimes, you know, the sentiment can change from hour to hour. And I think using a program and whatever it is, you know, it it definitely isn't a tool that needs to be probably in your toolbox here. Yeah. If I may add one small thing to to your point exactly. Like, you sometimes you need a tool to just make it faster.

19:41I think one of the biggest concerns if you're starting some social media listening is, like, alright. You're gonna spend all this money to go to this conference, and you're gonna be glued to your phone or laptop the entire time. That's that's not ideal. Right? You need to do it quickly and efficiently. But remember, you're there for the conference, for the material, for the meetings, for for everything else. So this is just a a small piece of that. So this all sounds like you you as as I'm listening, it sounds awesome. It sounds important.

20:12It sounds like why wouldn't MSLs be doing all this? But then there's always the but. Like, is legal cool with this? Like, is there is there what are the words of caution, and and what do you need to tell MSLs to be careful of? Boy, this is a topic that I think we could we could here here's the next half hour, folks. Part two. Part two. But I think, you know, one of the things that you absolutely need to do is make sure that

20:44that your legal team and your your medical affairs legal is absolutely on board with how to handle this. Mhmm. And I think I think there needs to be policies in place in order to kind of give you some guidelines and some guardrails so that things don't go off track. But I think some of the most important parts of it, and and this is just kinda summarizing it, is, you know, making sure that when you interact or or when you you you basically don't interact. I mean, don't retweet. Don't don't like. I mean, I think company policies will state that, you know, you don't wanna show this bias

21:18that's out there. And because you want you wanna be, you know, somebody who is unbiased. And I think also, you know, making sure that if if you are interacting with them, you know, making it nonpromotional is absolutely critical. And making sure that you just, you know, disclose that that you what your your purpose with them is with the with the the DOL, but also making sure that it fits within your company guidelines. Every company is different. Nobody is going to be, you know, have the right or the wrong way, but making sure that you do

21:51it ethically and keeping it within these regulatory guidelines is so key. And I think just being a good MSL and following what you normally would as an MSL is critical here because, honestly, you you can you can follow somebody, but but but reposting something they say could absolutely be, be viewed wrong by by somebody. Yeah. If if you're in a big enough company, there's there's a policy on this. You're gonna wanna look it up.

22:22It's almost certainly there. And and if I may add for, it's we talked a little bit about DOLs. You probably wanna lock down that definition pretty early. It's a lot easier talking to legal when you're like, I'm I'm talking about HCPs with an HCP audience. That jives because that's, you know, our podium presenters and our scientific expert and everything else. And if you start, you know, talking about influencers and other things, it's gonna get complicated really fast. So everything Kevin said, like, trust your instincts, follow your ethics, follow your

22:55policies, but also, like, prepare like, be prepared to plan early. Yep. So let's talk about that. You said plan early. What let's talk about, like, best practices, pitfalls, things things that we probably need to mention to, the audience to make sure that if you're kinda new to this or if you're if if you're if you're still kinda learning about it, what would be the rules of the road and best

23:28practices? Yeah. So, vetting DOLs is something Kevin mentioned. That's really important because you wanna make sure that you have a list that you're very comfortable with. Because especially if you're saying, well, we're we should prioritize these folks for engagement. Right? What are they appropriate to engage with? You wanna make sure that you're not sending any, you know, of your fellow teammates out to, you know, meet someone who gets their notoriety from, you know, criticizing pharma or making harsh comments, and and you could get them in really hot water.

23:59So that's that's one of the big things. The other thing, stepping back a little bit and thinking more big picture, is and Tom, you had said this digital first. Right? Like, these are a lot of cool tools. We can do a lot with them. AI is probably gonna be one of the most transformative things of this decade. Right? But it's not everything. Right? What's going to what the foundation what the core of this all is is good patient centric science. That's what what is ultimately going to inform medical practice.

24:32That's going to be what's most helpful. And these digital tools are something that can help us understand it better, help us disseminate it better, help us make sure that, you know, our plan plans with it, our medical strategies with it are better. But you need that at its core. If you're all in on digital, like, we can't run a trial right now by going to ChatGPT and saying, you know, run a three three hundred fifty patient trial with this drug and give me the results. We we don't trust that data. Right? You need to you need to have the strong science of the foundation and then use these digital

25:04tools as supplements to make sure that you're executing your medical strategy. You know, Connor nailed it. I mean, honestly, be prepared. You know, I think when you're you're doing these these, you know, assessments you know, also, sometimes you need to think a little bit outside the box of of just your role and make sure that you've got other people both on your commercial and your medical side, somewhat involved also because it because they may be interacting with them also. So I think, you know, making sure that you have your your internal or your your matrix, so to

25:40speak, in of your company also in mind because these influencers have no boundaries. There there is no territory for them. Everybody can can read their their posts. So making sure that everybody that that you that needs to be engaged is engaged before you go out and and make make some of these, interactions. Yeah. I I only see this becoming more important and growing because so I'm gonna explain like, I'm

26:12gonna I'm gonna out myself and and kind of share, like, my age, I started as a rep a million years ago when there was no Internet. Right? So the old school physicians that were practicing back then, they're all have either moved on or about to move on. So now as time has it, you're gonna get these younger, more seasoned, tech savvy MDs that are

26:44coming into existence that some of some of them may be experts in the digital world, or they may want to adopt the digital world, the social media world, as as a key part of their practice. It may just be something that that and we're seeing it. That's what this is. And it's become so important that you have to stay on top of it. So what other parting words do you have for MSLs that are out there that are like, I keep

27:16hearing about this. I know it's important, but, you know, I haven't fully maybe embraced it or I I need to do more. Like, what else can you add to what you I mean, you guys are awesome, but I'm just curious as to what other final piece of advice you can give to folks. Well, I I guess the final piece here that I would I would probably say is, you know, this is this is the the future. The future's here now, AI and in in all this digital is is how people are communicating. And so if you haven't gotten on this train yet, you're gonna be left at the station, and you

27:48are not you're not getting on. So I think one of the things that, you know, you just need to be aware of what's out there and and discuss this with your leadership about how your company is is handling AI and how they're handling this digital part because it is an important part and it and it goes very quickly. And so it needs to be I think you need to be able to be flexible and evolve. And, you know, that's one thing. You know, gotta remember patients are also looking at this, and so they're learning as as

28:20you go. So I think learning this entire piece is such an important part because at the end, the end user, which is the patient, is actual they're they're reading this. I mean, they can sign up for x just as easy as I can. So I think this is this is not the future is here today, and so we need to be very aware of what to what how to handle this. Yep. Yeah. You can't really say, like, I don't use AI. It's it's really I don't use AI yet. Because I mean, if you do a Google search now, like, you're using AI.

28:53Right. So you really I I would say, yes. This is coming. You have to be be as ready for it as you can. I mean, that's that's part of being an MSL, right, is adapting and being ready for change. Think you can do this in baby steps still. Like, just try it. Like, use ChatGPT once. Try it for something. I mean, obviously, be careful about what proprietary information goes into a public, you know, AI model. But just give it a shot, and little by little, you can learn, and that learning will snowball.

29:25So it's here. It's it's gonna keep growing. If you're not using it, you're just not using it yet. Well, listen. I am really, let's say, I know that the people that listen to this podcast are on the cutting edge. They all wanna do better. They're all motivated. They're growth oriented. Or they're going to break into this MSL role, and they're gonna wanna do this. So, guys, I can't thank you enough. I think this is incredibly valuable information.

29:57I encourage everybody to share this with friends because I really think that this is gonna be super, super important as we move forward into the rest of this year. And who knows what's gonna happen in 2026? That's whole another episode is, like, we talked about the evolution. Like, what's the future? What could happen? Because there's things are moving so fast. So, guys, thank you, Connor, Kevin. Thank you guys both for joining. You guys are amazing. I really appreciate you both. Alright. Thank you so much, Tom.

30:28Yeah, man. Guys, as always, appreciate you being here. Share this with others. Thank you for your support of the show, and we'll see you next time.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. The Wrong Voices: How Bad Mentors Can Ruin Your Career

    Nov 17, 202628 minVideo

    What qualifies someone to influence your future? Tom Caravela explains why career guidance should be filtered through relevant experience, current knowledge, credibility, and objectivity. He examines the risks of...

    Listen to the audio

    Credit the people on this episode

  2. Hidden Secret to Career Happiness and Longevity

    Nov 3, 202635 minVideo

    What turns an industry contact into a long-term ally? In this episode, Tom Caravela and Ed Doherty look beyond transactional networking to the genuine friendships that can shape a career in medical affairs. They discuss...

    Listen to the audio

    Credit the people on this episode

  3. How to AI-Proof Your Career: The 4 Pillars of Career Success

    Oct 20, 202623 minVideo

    Becoming undeniable is Tom Caravela’s answer to building career security in the age of AI. He breaks down four pillars you can control: skills, experience, relationships, and brand. Tom explains how continuous learning...

    Listen to the audio

    Credit the people on this episode

  4. How Medical Affairs Influences Decisions that Matter

    Oct 13, 202638 minVideo

    What happens after an MSL submits an insight? In this episode, Tom Caravela and Cameron Tew examine how field observations create value only when organizations decide what to do next. They discuss shared definitions,...

    Listen to the audio

    Credit the people on this episode

  5. Stop Being Your Own Worst Enemy

    Sep 29, 202619 minVideo

    In this episode, Tom Caravela discusses common mindset traps that can hold Medical Science Liaisons and aspiring MSLs back. He covers how to move past worst-case thinking, overanalysis, concern about others’ opinions,...

    Listen to the audio

    Credit the people on this episode